TacMed Australia has formed a partnership with Rheinmetall Defence Australia (RDA) to develop a Lynx KF 41 Ambulance Variant to be offered in RDA’s tender submission for Land 400 Phase 3.
TacMed, an emergency medical company that develops equipment, training and consulting solutions for high risk organisations and environments, has joined Team Lynx following the Commonwealth’s Australian Industry Capability roadshow in the first half of 2020.
TacMed CEO Jeremy Holder said RDA selected the company because of its ‘unique tactical medical experience and ability to provide specialised consulting services in the design of the vital Ambulance variant to support modern day warriors on the battlefield.’
“This is a significant partnership for TacMed Australia and it aligns with our mission of zero preventable deaths at the point of injury, no matter the environment. It cements our position as a leader in the field of critical casualty care in high-threat and complex environments,” Holder said.
“With over half of our company being former serving members of the ADF, TacMed will use its experience on the battlefields of Iraq and Afghanistan to play a role in developing the next generation of Australia’s armoured vehicles to protect and save soldiers’ lives.”
Rheinmetall has delivered three Lynx vehicles to compete in risk mitigation activity trials, which will put vehicles through lethality, mobility and blast tests.
If successful, the Lynx fleet will be manufactured in Queensland at Rheinmetall’s Military Vehicle Centre of Excellence at Redbank south west of Brisbane.
Other suppliers announced in recent weeks include Defcon Technologies, Minecorp, Rockpress and Queensland Gaskets.